FibroBiologics Inc

NASDAQ:FBLG  
0.63
-0.02 (-3.04%)
7:51:12 PM EDT: $0.63 0.00 (0.02%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

FibroBiologics Inc Stock, NASDAQ:FBLG

455 East Medical Center Boulevard, Suite 300, Houston, Texas 77598
United States of America
Phone: +1.281.671.5150
Number of Employees: 10
http://www.fibrobiologics.com

Description

FibroBiologics, Inc. engages in the development and commercialization of cell therapies. It focuses on treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. The firm�s product pipeline includes CybroCell, CYMS101, CYWC628, TCB190, and CYTER915. The company was founded by Peter O�Heeron on April 8, 2021 and is headquartered in Houston, TX.